Skip to main content
The drug industry's voice for manufacturing excellence
Production
Development
Information Technology
Compliance
Quality & Risk
Sections
Production
Development
Information Technology
Compliance
Quality & Risk
Facilities
Sectors
Special
Webinars
Podcasts
E-Handbooks
Industry News
Magazine Archives
Contact
Newsletter Subscription
Contact Us
Advertise
Follow us on
https://www.facebook.com/pages/Pharmaceutical-Manufacturing/140261116014887
http://www.linkedin.com/groups?gid=1813799
http://twitter.com/PharmaMfg
cGMPs
GlaxoSmithKline Bribery Scandal: Sexual Favors to Increase Sales?
China continues to step up its probe into alleged bribery by British drugmaker GlaxoSmithKline to illegally boost sales and inflate the price of its medicines.
July 18, 2013
Add Us On Google
1660601239043 Gsk
Sign up for our eNewsletters
Get the latest news and updates
Sign Up
Related
Charles River reports lower Q4 2025 revenue in struggling CDMO business
Charles River reports lower Q4 2025 revenue in struggling CDMO business
Fujifilm doubles quality control footprint at Danish commercial-scale manufacturing site
Fujifilm doubles quality control footprint at Danish commercial-scale manufacturing site
2026 Manufacturing Pharma Trends for Life Sciences
Sponsored
2026 Manufacturing Pharma Trends for Life Sciences
2026 AI Trends in Life Sciences
Sponsored
2026 AI Trends in Life Sciences
Trending
Biopharma is expecting much of CDMOs, but are they up to the challenge?
Catalent invests in biologics, oral drug manufacturing following refinancing
Radiopharma’s growing pipeline puts capacity to the test
Sponsored Picks
Sponsored
2026 Manufacturing Pharma Trends for Life Sciences
Sponsored
2026 AI Trends in Life Sciences
Sponsored
2026 Manufacturing Medical Device Trends for Life Sciences
Load More Content